Menu
/REGISTER
Montecito
Pac Premier
Loading...
You are here:  Home  >  'osteoporosis'
Latest

Amgen’s Evenity osteoporosis treatment priced at $21,900 per year

By   /  Tuesday, April 16th, 2019  /  Biotech, East Ventura County, Latest news  /  Comments Off on Amgen’s Evenity osteoporosis treatment priced at $21,900 per year

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval for osteoporosis drug Evenity

By   /  Tuesday, April 9th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology  /  Comments Off on Amgen gets FDA approval for osteoporosis drug Evenity

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

FDA committee OKs Amgen’s Evenity

By   /  Thursday, January 17th, 2019  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on FDA committee OKs Amgen’s Evenity

A U.S. Food and Drug Administration advisory committee voted in favor of a new approval for Amgen’s osteoporosis treatment Evenity for use by postmenopausal women. The Bone, Reproductive and Urologic Drugs Advisory Committee voted to approve the expanded use of the treatment following the release of new safety and efficacy data and emphasized the need Read More →

Read More →
Latest

Amgen shares climb after it resubmits Evenity drug application to FDA

By   /  Friday, July 13th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen shares climb after it resubmits Evenity drug application to FDA

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Santa Barbara doctor writes memoir of Vietnam War

By   /  Friday, June 2nd, 2017  /  Central Coast Health Watch, Features, Latest news  /  Comments Off on Santa Barbara doctor writes memoir of Vietnam War

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen seeks to market osteoporosis drug in Japan

By   /  Tuesday, December 20th, 2016  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen seeks to market osteoporosis drug in Japan

Thousand Oaks biotech giant Amgen is seeking marketing approval in Japan for osteoporosis drug romosozumab, the company announced on Dec. 20. Amgen submitted the request to the Pharmaceuticals and Medical Devices Agency in Japan, where an estimated 12 million people have a high risk of bone fracture. The company is co-developing the drug worldwide with Euronext Read More →

Read More →
Latest

Study results positive for drug Amgen developing to treat osteoporosis

By   /  Monday, March 21st, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Study results positive for drug Amgen developing to treat osteoporosis

Thousand Oaks-based biotech giant Amgen and Brussels, Belgium-based UCB announced positive results in a Phase 3 trial of romosozumab, an antibody designed to treat osteoporosis. The drug works by inhibiting a protein which results in increased bone formation and decreased bone breakdown. However, the drug is not approved by any regulatory authority for use to Read More →

Read More →